Traders sold shares of Express Scripts Holding Co (NASDAQ:ESRX) on strength during trading on Friday. $19.84 million flowed into the stock on the tick-up and $44.89 million flowed out of the stock on the tick-down, for a money net flow of $25.05 million out of the stock. Of all equities tracked, Express Scripts had the 11th highest net out-flow for the day. Express Scripts traded up $1.48 for the day and closed at $96.81
A number of equities analysts have recently weighed in on the company. BidaskClub raised Express Scripts from a “hold” rating to a “buy” rating in a research report on Tuesday, September 18th. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research report on Monday, September 17th. Royal Bank of Canada set a $101.00 target price on Express Scripts and gave the stock a “buy” rating in a research report on Thursday, November 1st. Cowen reaffirmed a “buy” rating and set a $88.00 target price on shares of Express Scripts in a research report on Friday, November 2nd. Finally, Zacks Investment Research reaffirmed a “buy” rating and set a $109.00 target price on shares of Express Scripts in a research report on Tuesday, November 13th. One analyst has rated the stock with a sell rating, thirteen have issued a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. Express Scripts has an average rating of “Hold” and a consensus target price of $90.73.
The firm has a market capitalization of $53.75 billion, a PE ratio of 13.64, a price-to-earnings-growth ratio of 1.20 and a beta of 0.89. The company has a quick ratio of 0.65, a current ratio of 0.77 and a debt-to-equity ratio of 0.63.
In related news, Director Mahon Thomas P. Mac sold 5,234 shares of the company’s stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $99.50, for a total transaction of $520,783.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.79% of the company’s stock.
A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in Express Scripts by 1.5% during the third quarter. Vanguard Group Inc. now owns 40,305,179 shares of the company’s stock worth $3,829,396,000 after buying an additional 580,336 shares in the last quarter. BlackRock Inc. grew its holdings in Express Scripts by 0.4% during the third quarter. BlackRock Inc. now owns 35,572,234 shares of the company’s stock worth $3,379,717,000 after buying an additional 148,049 shares in the last quarter. Capital International Investors grew its holdings in Express Scripts by 370.4% during the third quarter. Capital International Investors now owns 11,842,955 shares of the company’s stock worth $1,125,199,000 after buying an additional 9,325,455 shares in the last quarter. Northern Trust Corp grew its holdings in Express Scripts by 0.4% during the second quarter. Northern Trust Corp now owns 10,205,190 shares of the company’s stock worth $787,943,000 after buying an additional 40,656 shares in the last quarter. Finally, Abrams Capital Management L.P. grew its holdings in Express Scripts by 20.3% during the third quarter. Abrams Capital Management L.P. now owns 3,192,304 shares of the company’s stock worth $303,301,000 after buying an additional 539,203 shares in the last quarter. Institutional investors and hedge funds own 83.15% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This story was first published by WKRB News and is owned by of WKRB News. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://www.wkrb13.com/2018/11/24/investors-sell-shares-of-express-scripts-esrx-on-strength-esrx.html.
About Express Scripts (NASDAQ:ESRX)
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Read More: What is an Initial Public Offering (IPO)?
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.